Medication Affordability and Patent Integrity Act

This bill would require companies seeking approval for a new drug or biological product to share certain patent-related information with both the FDA and the U.S. Patent and Trademark Office, and to confirm that the information they give to both agencies is complete and consistent. The bill covers patents related to the drug itself, how it's used, and how it's made. If a patent holder fails to share the required information — whether on purpose or by accident — the bill creates a legal defense that others can use if they are sued for patent infringement.

Your Vote